Ardeparin cleared for marketing.
D017277:Drug Approval; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D007720:Knee Prosthesis; D013924:Thrombophlebitis / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
D006495:Heparin, Low-Molecular-Weight; C093450:ardeparin